Exchange: NASDAQ Sector: Healthcare Industry: Pharmaceutical Retailers
-2.41% $2.83
America/New_York / 25 apr 2024 @ 16:00
FUNDAMENTALS | |
---|---|
MarketCap: | 4.76 mill |
EPS: | -4.40 |
P/E: | -0.640 |
Earnings Date: | N/A |
SharesOutstanding: | 1.683 mill |
Avg Daily Volume: | 0.0773 mill |
RATING 2024-04-25 |
---|
B+ |
Neutral |
RATINGS | ||
---|---|---|
Rating CashFlow: | Buy | |
Return On Equity: | Sell | |
Return On Asset: | Neutral | |
DE: | Strong Buy | |
P/E: | Neutral | |
Price To Book: | Sell |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
2/22 | 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | n/a | n/a | n/a | |||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -0.640 | sector: PE -3.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
-0.09x |
Company: PE -0.640 | industry: PE 7.30 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ 2.55 - 3.11 ( +/- 9.96%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2018-06-28 | Liu Lei | Sell | 225 000 | Common Stock |
2018-03-30 | Liu Lei | Buy | 900 000 | Common Stock |
2018-03-30 | Zhao Ming | Buy | 30 000 | Common Stock |
2017-01-19 | Hillhouse Capital Management, Ltd. | Buy | 0 | Common Stock, par value $0.001 per share |
2016-10-11 | Liu Lei | Buy | 949 000 | Common Stock |
INSIDER POWER |
---|
0.00 |
Last 25 transactions |
Buy: 3 667 365 | Sell: 225 000 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 |
Volume Signals | |
---|---|
Price | $2.83 (-2.41% ) |
Volume | 0.0022 mill |
Avg. Vol. | 0.0773 mill |
% of Avg. Vol | 2.86 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
China Jo-Jo Drugstores, Inc., together with its subsidiaries, operates as a retailer and distributor of pharmaceutical and other healthcare products in the People's Republic of China. The company operates through four segments: Retail Drugstores, Online Pharmacy, Drug Wholesale, and Herb Farming. Its stores provide various pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines (TCM), personal and family care products, and medical devices, as well as convenience products, such as consumable, seasonal, and promotional items. The company also operates licensed doctors of Western medicine and TCM on site for consultation, examination, and treatment of common ailments at scheduled hours. In addition, it operates online drugstore that retails OTC drugs and nutritional supplements, as well as sells products through third-party platforms. Further, the company distributes third-party pharmaceutical products primarily to trading companies, as well as cultivates and wholesales herbs used for TCM. As of March 31, 2021, it had 109 retail pharmacies under the Jiuzhou Grand Pharmacy name, as well as 4 drugstores. The company was founded in 2003 and is headquartered in Hangzhou, the People's Republic of China.